[PDF][PDF] Inhibition of RAF isoforms and active dimers by LY3009120 leads to anti-tumor activities in RAS or BRAF mutant cancers
…, WP Lu, BD Smith, S Vogeti, TJ Rutkoski, S Wise… - Cancer cell, 2015 - cell.com
LY3009120 is a pan-RAF and RAF dimer inhibitor that inhibits all RAF isoforms and
occupies both protomers in RAF dimers. Biochemical and cellular analyses revealed that …
occupies both protomers in RAF dimers. Biochemical and cellular analyses revealed that …
[PDF][PDF] Ripretinib (DCC-2618) is a switch control kinase inhibitor of a broad spectrum of oncogenic and drug-resistant KIT and PDGFRA variants
…, MD Kaufman, WP Lu, A Gupta, CB Leary, SC Wise… - Cancer cell, 2019 - cell.com
Ripretinib (DCC-2618) was designed to inhibit the full spectrum of mutant KIT and PDGFRA
kinases found in cancers and myeloproliferative neoplasms, particularly in gastrointestinal …
kinases found in cancers and myeloproliferative neoplasms, particularly in gastrointestinal …
cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype
LM Smith, SC Wise, DT Hendricks, AL Sabichi, T Bos… - Oncogene, 1999 - nature.com
We have previously demonstrated decreased Jun/AP-1 activity in the breast cancer cell line
MCF-7 when compared to normal or immortalized mammary epithelial cells. In this paper, …
MCF-7 when compared to normal or immortalized mammary epithelial cells. In this paper, …
[PDF][PDF] Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036
WW Chan, SC Wise, MD Kaufman, YM Ahn… - Cancer cell, 2011 - cell.com
Acquired resistance to ABL1 tyrosine kinase inhibitors (TKIs) through ABL1 kinase domain
mutations, particularly the gatekeeper mutant T315I, is a significant problem for patients with …
mutations, particularly the gatekeeper mutant T315I, is a significant problem for patients with …
Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone.
HS Camp, O Li, SC Wise, YH Hong, CL Frankowski… - Diabetes, 2000 - Am Diabetes Assoc
The antidiabetic thiazolidinediones, which include troglitazone and rosiglitazone, are ligands
for the nuclear receptor peroxisome proliferator-activated receptor (PPAR)-gamma and …
for the nuclear receptor peroxisome proliferator-activated receptor (PPAR)-gamma and …
CT angiography: in vitro comparison of five reconstruction methods
…, TA Iyriboz, Y Liu, SW Wise… - American journal of …, 2001 - Am Roentgen Ray Soc
OBJECTIVE. Five image reconstruction techniques have been used with CT angiography:
axial (cross-sectional), maximum intensity projection (MIP), curved multiplanar reconstruction (…
axial (cross-sectional), maximum intensity projection (MIP), curved multiplanar reconstruction (…
The Selective Tie2 Inhibitor Rebastinib Blocks Recruitment and Function of Tie2Hi Macrophages in Breast Cancer and Pancreatic Neuroendocrine Tumors
…, J Pignatelli, BD Smith, E Kadioglu, SC Wise… - Molecular cancer …, 2017 - AACR
Tumor-infiltrating myeloid cells promote tumor progression by mediating angiogenesis, tumor
cell intravasation, and metastasis, which can offset the effects of chemotherapy, radiation, …
cell intravasation, and metastasis, which can offset the effects of chemotherapy, radiation, …
Comparative assessment of CT and sonographic techniques for appendiceal imaging
SW Wise, MR Labuski, CJ Kasales… - American Journal of …, 2001 - Am Roentgen Ray Soc
OBJECTIVE. We performed a comparative assessment of CT and sonographic techniques
used to assess appendicitis. MATERIALS AND METHODS. One hundred patients with …
used to assess appendicitis. MATERIALS AND METHODS. One hundred patients with …
Discovery of 1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea (LY3009120) as a Pan-RAF Inhibitor with Minimal Paradoxical …
…, TJ Rutkoski, BD Smith, S Vogeti, D Miller, SC Wise… - 2015 - ACS Publications
The RAS-RAF-MEK-MAPK cascade is an essential signaling pathway, with activation
typically mediated through cell surface receptors. The kinase inhibitors vemurafenib and …
typically mediated through cell surface receptors. The kinase inhibitors vemurafenib and …
Vimseltinib: a precision CSF1R therapy for tenosynovial giant cell tumors and diseases promoted by macrophages
BD Smith, MD Kaufman, SC Wise, YM Ahn… - Molecular cancer …, 2021 - AACR
Macrophages can be co-opted to contribute to neoplastic, neurologic, and inflammatory
diseases. Colony-stimulating factor 1 receptor (CSF1R)-dependent macrophages and other …
diseases. Colony-stimulating factor 1 receptor (CSF1R)-dependent macrophages and other …